Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Familial spontaneous pneumothorax (FSP) is an autosomal dominant lung disorder characterized by recurrent pneumothoraces and bullous changes in the lung parenchyma. Germline heterozygous variants in the folliculin gene (FLCN) underlie both Birt-Hogg-Dubé syndrome and isolated familial PSP, implicating FLCN as a critical regulator of pulmonary extracellular matrix and pleural integrity in familial spontaneous pneumothorax.
The FLCN–familial spontaneous pneumothorax association is classified as Strong based on identification of pathogenic FLCN variants in ≥4 unrelated pedigrees (PMID:15657874;PMID:28839995;PMID:31625278;PMID:31567476), consistent autosomal dominant segregation and concordant functional data.
FSP due to FLCN follows an autosomal dominant inheritance pattern with high penetrance of lung cyst formation and pneumothorax. In a multigenerational Turkish kindred, a truncating mutation c.1273C>T (p.Gln425Ter) (PMID:31625278) co-segregated with PSP in five affected relatives. Across >20 families and >80 affected individuals, variant classes include frameshift, nonsense, splice-site, small indels and intragenic deletions.
Minigene splicing assays confirmed that noncanonical intronic variants (e.g., c.1300+5G>A) disrupt FLCN RNA processing, leading to exon skipping and protein truncation (PMID:36410626). In promoter deletion studies, FLCN haploinsufficiency in lung cyst tissue demonstrated reduced transcript and protein levels, supporting a loss-of-function mechanism (PMID:26398834).
No studies to date have refuted the FLCN–FSP link, and no alternative genes have been consistently implicated in familial PSP outside of FLCN in comprehensive screening studies.
Cumulative genetic and functional data provide strong support for routine FLCN testing in patients with familial PSP, guiding surveillance for renal neoplasia. Identification of truncating FLCN variants enables definitive diagnosis, risk stratification, and tailored clinical management.
Key Take-home: Heterozygous loss-of-function FLCN variants cause autosomal dominant familial spontaneous pneumothorax with strong genetic and functional evidence, justifying genetic testing in affected families.
Gene–Disease AssociationStrongVariants in FLCN identified in ≥4 unrelated families with autosomal dominant segregation and functional concordance Genetic EvidenceStrongMultiple truncating, splice-site, indel and deletion variants in >80 probands across >20 families; segregation in 5 affected relatives Functional EvidenceModerateSplicing assays and promoter deletion studies demonstrate haploinsufficiency and disrupted RNA processing in concordance with PSP phenotype |